AEterna Zentaris to Present at Upcoming CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference in New Yo
April 05 2007 - 10:00AM
PR Newswire (US)
QUEBEC CITY, April 5 /PRNewswire-FirstCall/ -- AEterna Zentaris
Inc. (TSX: AEZ; Nasdaq: AEZS) today announced that its President
and Chief Executive Officer, David J. Mazzo, Ph.D., will present a
Company overview at the CIBC World Markets Annual Biotechnology
& Specialty Pharmaceuticals Conference on Wednesday, April 11,
2007 at 10:20 a.m. ET, in Room 3.05 of the Millennium Broadway
Hotel in New York City. A live webcast of this presentation will be
available on the Company's website at
http://www.aeternazentaris.com/ in the Investors section. A replay
will also be available for a period of 30 days. About AEterna
Zentaris Inc. AEterna Zentaris Inc. is a late-stage, global
biopharmaceutical company focused on endocrine therapy and oncology
with proven expertise in drug discovery, development and
commercialization. News releases and additional information are
available at http://www.aeternazentaris.com/. DATASOURCE: AETERNA
ZENTARIS INC. CONTACT: Jenene Thomas, Senior Director, Investor
Relations & Corporate Communications, (418) 655-6420, ; Paul
Burroughs, Media Relations, (418) 652-8525, ext. 406,
Copyright